Search for: "Janssen v. Janssen"
Results 201 - 220
of 385
Sorted by Relevance
|
Sort by Date
10 Jun 2016, 3:00 am
Following Montgomery v. [read post]
29 Jul 2009, 7:47 am
Janssen Pharmaceutica, Inc. [read post]
10 Jun 2016, 3:00 am
Following Montgomery v. [read post]
27 Oct 2021, 5:15 am
Janssen Pharmaceutica, N.V., No. 21-202 (NHK-Fintiv rule for denying petitions; appealability of IPR petition denial); Apple Inc. v. [read post]
20 Apr 2017, 2:44 am
Brian Corderyby Steven Willis Given the furore surrounding Birss J’s decision on the non-technical issues in Unwired Planet v Huawei earlier this month, which included the first determination of FRAND terms by an English Court (reported on by my colleague Rachael here), it would have been easy to miss the first appellate Court judgment on the related technical issues which was handed down last week. [read post]
14 Mar 2016, 3:23 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
8 Dec 2023, 7:58 am
Janssen, 2014). [read post]
4 Mar 2008, 1:49 am
Janssen, discussing the new Federal Rules of Civil Procedure and their impact on litigators can be downloaded at [feeds.feedburner]. com/Westcast. [read post]
23 May 2017, 3:23 am
The practical effect of the Supreme Court’s decision in Heartland v Kraft Foods will be to restrict a patentee’s choice to bring cases in patentee-friendly jurisdictions where findings of infringement and damages awards are higher than in other venues, namely the Eastern District of Texas. [read post]
3 Apr 2009, 4:50 am
: Scinopharm Taiwan Ltd v Eli Lily & Co (PatLit) Naglazyme (Galsulfase) - Brazil: Federal Court of the First Region orders government to supply unapproved drug Naglazyme (IP tango) Plavix (Clopidogrel) – US: Bristol-Myers Squibb to pay $2.1 million to settle FTC claims it issues misleading statement about proposed Plavix patent deal with Apotex, violating court orders from earlier anti-trust cases (Law360) Razadyne (Galantamine) – US: Johnson & Johnson… [read post]
6 Oct 2021, 5:16 am
The key authority remained Gore v Geox [2008] EWCA Civ 622. [read post]
4 Apr 2017, 2:51 am
Even though IP rights have been mentioned in IIAs as protected investments for decades, Eli Lilly v. [read post]
17 Mar 2022, 2:32 pm
Janssen Biotech, Inc., 759 F.3d 1285, 1300–01 (Fed. [read post]
24 Feb 2016, 5:14 am
Janssen Pharmaceuticals, Inc., 2016 WL 633673 (E.D. [read post]
16 Mar 2007, 5:59 am
State and Janssen v. [read post]
12 Apr 2023, 4:00 am
Sandoz Canada Inc., 2023 FC 243 at para 6 quoting from the Regulatory Impact Analysis Statement, (2017) Canada Gazette, Part 1, Vol 151, No 28 at 3317. [3] See Section 7(1)(d), Patented Medicines (NOC) Regulations. [4] See Section 6(3), Patented Medicines (Notice of Compliance) Regulations, subsections (a0 and (b) provide for a counterclaim against asserted claims in a patent or in a certificate of supplementary protection respectively. [5] See Janssen Inc v Apotex Inc, 2022 FCA… [read post]
9 Jan 2022, 1:45 am
In Abbvie v Janssen, for example, a claim directed to a functionally defined anti-Il-12 antibody was found invalid for lack of written description despite disclosure in the specification of 300 example antibodies. [read post]
7 Mar 2016, 1:55 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A comprehensive… [read post]
28 Apr 2017, 9:56 am
& Bayer Pharma AG v. [read post]
15 Aug 2013, 2:36 pm
Janssen v. [read post]
